Equities

SINTX Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

SINTX Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.72
  • Today's Change-0.045 / -1.63%
  • Shares traded28.86k
  • 1 Year change-19.53%
  • Beta0.6479
Data delayed at least 15 minutes, as of Mar 06 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year SINTX Technologies Inc had net income fall 33.48% from a loss of 8.26m to a larger loss of 11.02m despite revenues that grew 9.90% from 2.63m to 2.89m over the same period.
Gross margin52.05%
Net profit margin-775.12%
Operating margin-798.03%
Return on assets-86.86%
Return on equity-343.31%
Return on investment-121.23%
More ▼

Cash flow in USDView more

In 2024, SINTX Technologies Inc increased its cash reserves by 7.72%, or 258.00k. Cash Flow from Financing totalled 9.09m or 315.00% of revenues. In addition the company used 8.64m for operations while cash used for investing totalled 194.00k.
Cash flow per share-4.40
Price/Cash flow per share--
Book value per share1.13
Tangible book value per share1.00
More ▼

Balance sheet in USDView more

SINTX Technologies Inc uses little debt in its capital structure as supported by a debt to capital ratio of 1.43%.
Current ratio1.70
Quick ratio1.60
Total debt/total equity0.0145
Total debt/total capital0.0143
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.